Gil-Delgado M - Search Results

1

The role of irinotecan and oxaliplatin in the treatment of advanced colorectal cancer.

Khayat D, Gil-Delgado M, Antoine EC, Nizri D, Bastian G. Khayat D, et al. Among authors: gil delgado m. Oncology (Williston Park). 2001 Apr;15(4):415-29; discussion 429-30, 433-4. Oncology (Williston Park). 2001. PMID: 11346931 Free article.

2

European experience with irinotecan plus fluorouracil/folinic acid or mitomycin.

Khayat D, Gil-Delgado M, Antoine EC, Coeffic D, Benhammouda A, Grapin JP, Bastian G. Khayat D, et al. Oncology (Williston Park). 1998 Aug;12(8 Suppl 6):64-7. Oncology (Williston Park). 1998. PMID: 9726094 Free article. Review.

3

Prospective phase II trial of iriontecan, 5-fluorouracil, and leucovorin in combination as salvage therapy for advanced colorectal cancer.

Gil-Delgado MA, Guinet F, Castaing D, Adam R, Coeffic D, Durrani AK, Bismuth H, Khayat D. Gil-Delgado MA, et al. Am J Clin Oncol. 2001 Feb;24(1):101-5. doi: 10.1097/00000421-200102000-00021. Am J Clin Oncol. 2001. PMID: 11232943 Clinical Trial.

4

Phase I-II study of irinotecan in combination with mitomycin C in patients with advanced gastrointestinal cancer.

Gil-Delgado MA, Antoine EC, Guinet F, Bassot V, Grapin JP, Benhammonda A, Adam R, Castaing D, Bismuth H, Khayat D. Gil-Delgado MA, et al. Am J Clin Oncol. 2001 Jun;24(3):251-4. doi: 10.1097/00000421-200106000-00008. Am J Clin Oncol. 2001. PMID: 11404495 Clinical Trial.

5

[Irinotecan in combination for colon cancer].

Ducreux M, Gil-Delgado M, André T, Ychou M, de Gramond A, Khayat D. Ducreux M, et al. Bull Cancer. 1998 Dec;Spec No:43-6. Bull Cancer. 1998. PMID: 9932084 Free article. Review. French.

6

Serum caspase-1 levels in metastatic melanoma patients: relationship with tumour burden and non-response to biochemotherapy.

Mouawad R, Antoine EC, Gil-Delgado M, Khayat D, Soubrane C. Mouawad R, et al. Among authors: gil delgado m. Melanoma Res. 2002 Aug;12(4):343-8. doi: 10.1097/00008390-200208000-00006. Melanoma Res. 2002. PMID: 12170183

7

A comparative study of Fas and Fas-ligand expression during melanoma progression.

Soubrane C, Mouawad R, Antoine EC, Verola O, Gil-Delgado M, Khayat D. Soubrane C, et al. Br J Dermatol. 2000 Aug;143(2):307-12. doi: 10.1046/j.1365-2133.2000.03655.x. Br J Dermatol. 2000. PMID: 10951137

8

Is there any relationship between interleukin-6/interleukin-6 receptor modulation and endogenous interleukin-6 release in metastatic malignant melanoma patients treated by biochemotherapy?

Mouawad R, Khayat D, Merle S, Antoine EC, Gil-Delgado M, Soubrane C. Mouawad R, et al. Melanoma Res. 1999 Apr;9(2):181-8. doi: 10.1097/00008390-199904000-00011. Melanoma Res. 1999. PMID: 10380941

9

Long-Term Survival in Gastroesophageal Junction Adenocarcinoma: Ramucirumab.

Gil-Delgado MA, Lucidarme O, Bachet JB, Mahi N, Khayat D. Gil-Delgado MA, et al. Case Rep Gastroenterol. 2018 Aug 31;12(2):532-539. doi: 10.1159/000490906. eCollection 2018 May-Aug. Case Rep Gastroenterol. 2018. PMID: 30283289 Free PMC article.

10

Phase II trial of weekly intravenous vinorelbine in first-line advanced breast cancer chemotherapy.

Fumoleau P, Delgado FM, Delozier T, Monnier A, Gil Delgado MA, Kerbrat P, Garcia-Giralt E, Keiling R, Namer M, Closon MT, et al. Fumoleau P, et al. J Clin Oncol. 1993 Jul;11(7):1245-52. doi: 10.1200/JCO.1993.11.7.1245. J Clin Oncol. 1993. PMID: 8315421 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26 results

Search Page

Filters